BeStock  
Stocks › Biotechnology › STTK

Shattuck Labs STTK

US equityMarket cap rank #3657Biotechnology
$5.66 −$0.21 (-3.50%)
Market closed · Oct 8, 6:40 am ET · Last extended-hours $5.66 0.00%
Open$5.76
Prev close$5.86
Day range$5.55 – $5.83
Volume1.11M
Market cap$567.55M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$0.00
Operating profit-$16.16M-24.0% YoY
Net profit-$15.15M-21.6% YoY
Diluted EPS-$0.12+50.0% YoY
Free cash flow-$10.33M+1.0% YoY
Operating cash flow-$10.19M

Revenue, last 8 quarters

$3.0MSep '24$0.0Dec '24$0.0Mar '25$0.0Jun '25$1.0MSep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26

Net profit, last 8 quarters

$-16.7MSep '24$-18.7MDec '24$-13.7MMar '25$-12.5MJun '25$-10.1MSep '25$-12.6MDec '25$-14.8MMar '26$-15.2MJun '26

Diluted EPS by quarter

-0.33Sep '24-0.37Dec '24-0.27Mar '25-0.24Jun '25-0.14Sep '25-0.12Dec '25-0.13Mar '26-0.12Jun '26

Free cash flow by quarter

$-16.1MSep '24$-17.4MDec '24$-12.0MMar '25$-10.4MJun '25$-9.0MSep '25$-8.5MDec '25$-13.4MMar '26$-10.3MJun '26

Annual revenue

$9.9MFY20$30.0MFY21$652.0KFY22$1.7MFY23$5.7MFY24$1.0MFY25

Profitability & balance sheet

Operating margin-5,578.6%
Net margin-5,256.8%
Return on equity-39.2%
Return on assets-36.9%
Return on invested capital-40.7%
Current ratio27.59
Liabilities / assets4.3%
Cash & investments$208.30M
Total debt$1.80M
Net cash (debt)$206.50M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $0.00 $0.00 $1.00M $0.00 $1.00M
Total Operating Revenue $0.00 $0.00 $1.00M $0.00 $1.00M
Operating Expense $16.16M $15.55M $52.51M $13.37M $11.72M
Selling and Admin Expenses $4.46M $4.60M $17.24M $4.32M $4.10M
-General & Admin Expense $4.46M $4.60M $17.24M $4.32M $4.10M
Research & Development $11.70M $10.95M $35.27M $9.06M $7.62M
Operating Profit -$16.16M -$15.55M -$51.51M -$13.37M -$10.72M
Net Non-Operating Interest Income (Expense) $1.03M $779,000.00 $2.70M – –
Non-Operating Interest Income $1.03M $779,000.00 $2.70M – –
Other Income (Expense) -$26,000.00 -$1,000.00 -$4,000.00 -$1.93M $660,000.00
Other Non-Operating Income (Expenses) -$26,000.00 -$1,000.00 -$4,000.00 -$1.93M $660,000.00
Pretax Profit -$15.15M -$14.77M -$48.81M -$12.59M -$10.06M
Net Profit -$15.15M -$14.77M -$48.81M -$12.59M -$10.06M
Profit from Continuing Operations -$15.15M -$14.77M -$48.81M -$12.59M -$10.06M
Net Income to Parent Company -$15.15M -$14.77M -$48.81M -$12.59M -$10.06M
Net Income to Common Stockholders -$15.15M -$14.77M -$48.81M -$12.59M -$10.06M
Basic EPS -$0.12 -$0.13 -$0.70 -$0.12 -$0.14
Diluted EPS -$0.12 -$0.13 -$0.70 -$0.12 -$0.14

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $220.67M $102.12M $91.03M $91.03M $100.33M
Total Current Assets $213.27M $93.75M $82.48M $82.48M $90.72M
Cash and Cash Equivalents & Short-Term Investments $208.30M $90.42M $78.07M $78.07M $86.13M
-Cash and Cash Equivalents $63.30M $90.42M $54.19M $54.19M $42.55M
-Short Term Investments $145.00M $0.00 $23.87M $23.87M $43.58M
Other Current Assets $4.97M $3.33M $4.41M $4.41M $4.59M
Total Non-Current Assets $7.39M $8.37M $8.55M $8.55M $9.61M
Net PPE $4.51M $5.35M $6.11M $6.11M $7.05M
Investments and Advances $1.00M $1.00M $1.00M $1.00M –
Other Non-Current Assets $1.88M $2.02M $1.44M $1.44M $2.56M
Total Liabilities $9.53M $6.29M $8.64M $8.64M $7.09M
Total Current Liabilities $7.73M $4.25M $7.05M $7.05M $5.34M
Payables $3.94M $1.25M $2.10M $2.10M $1.16M
-Accounts Payable $3.94M $1.25M $2.10M $2.10M $1.16M
Current Accrued Expenses $1.03M $1.06M $1.11M $1.11M $753,000.00
Short-Term Debt and Capital Lease Obligation $874,000.00 $852,000.00 $837,000.00 $837,000.00 $873,000.00
-Current Capital Lease Obligation $874,000.00 $852,000.00 $837,000.00 $837,000.00 $873,000.00
Other Current Liabilities $351,000.00 $335,000.00 $236,000.00 $236,000.00 $213,000.00
Total Non-Current Liabilities $1.80M $2.04M $1.58M $1.58M $1.76M
Long Term Debt and Capital Lease Obligation $1.80M $2.04M $1.58M $1.58M $1.76M
-Long Term Capital Lease Obligation $1.80M $2.04M $1.58M $1.58M $1.76M
Total Equity $211.14M $95.84M $82.39M $82.39M $93.24M
Stockholders' Equity $211.14M $95.84M $82.39M $82.39M $93.24M
Capital Stock $10,000.00 $7,000.00 $7,000.00 $7,000.00 $7,000.00
-Common Stock $10,000.00 $7,000.00 $7,000.00 $7,000.00 $7,000.00
Additional Paid-In Capital $671.64M $541.12M $512.91M $512.91M $511.17M
Retained Earnings -$460.45M -$445.30M -$430.53M -$430.53M -$417.94M
Gains/Losses Not Affecting Retained Earnings -$63,000.00 $0.00 $6,000.00 $6,000.00 $3,000.00
-Gross PPE – – $22.79M $22.79M –
-Accumulated Depreciation – – -$16.67M -$16.67M –

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$10.19M -$13.42M -$39.88M -$8.49M -$8.93M
Net cash flow from continuing operations -$10.19M -$13.42M -$39.88M -$8.49M -$8.93M
Net Income from Continuing Operations -$15.15M -$14.77M -$48.81M -$12.59M -$10.06M
Depreciation & Depletion & Amortization $851,000.00 $891,000.00 $3.69M $906,000.00 $917,000.00
Other Non-Cash Items -$549,000.00 $132,000.00 -$599,000.00 $132,000.00 -$972,000.00
Change in Working Capital $2.13M -$2.05M -$785,000.00 $1.71M -$477,000.00
-Change in Prepaid Assets -$1.64M $1.08M $1.82M $180,000.00 -$382,000.00
-Change in Payables and Accrued Expense $3.32M -$2.87M -$1.76M $1.82M $0.00
-Change in Other Current Assets $6,000.00 -$32,000.00 $79,000.00 -$12,000.00 $59,000.00
-Change in Other Current Liabilities $441,000.00 -$225,000.00 -$922,000.00 -$278,000.00 -$154,000.00
Net cash flow from investing -$144.95M $23.85M -$7.89M $20.00M -$43.49M
Net Cash Flow from Continuing Investing Activities -$144.95M $23.85M -$7.89M $20.00M -$43.49M
Net Investment Purchase and Sale -$144.81M $23.85M -$7.82M $20.00M -$43.42M
Financing Cash Flow $128.01M $25.80M $44.57M $134,000.00 $44.50M
Net Cash Flow from Continuing Financing Activities $128.01M $25.80M $44.57M $134,000.00 $44.50M
Net Common Stock Issuance $80.43M $20.56M $44.48M -$5,000.00 $44.48M
Proceeds from Stock Option Exercised $47.59M $5.50M $164,000.00 $139,000.00 $17,000.00
Net Other Financing Charges -$7,000.00 -$262,000.00 -$65,000.00 $0.00 $0.00
Ending Cash Balance $63.30M $90.42M $54.19M $54.19M $42.55M
Net Change in Cash -$27.12M $36.23M -$3.20M $11.64M -$7.92M
Beginning Cash Balance $90.42M $54.19M $57.39M $42.55M $50.47M
Free Cash Flow -$10.33M -$13.42M -$39.95M -$8.49M -$9.00M
Gain/Loss from Continuing Operations – – $81,000.00 $34,000.00 –
Net PPE Purchase and Sale – – -$71,000.00 $0.00 -$71,000.00

Discussion

No comments yet — be the first to weigh in on STTK.

Leave a comment

Scroll to Top